Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies

Autoimmunity

Volumn 39, Issue 3, 2006, Pages 243-247

  Mielnik, Pawel ^a   Wiesik Szewczyk, Ewa ^a   Olesinska, Marzena ^a   Chwalinska Sadowska, Hanna ^a   Zabek, Jakub ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Aminoacyl tRNA synthetases; Anti Jo 1 antibodies; Idiopathic inflammatory myopathies; Raynaud's phenomenon

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; JO 1 ANTIBODY; METHOTREXATE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FREQUENCY ANALYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; MUSCLE STRENGTH; MYALGIA; MYOSITIS; PROGNOSIS; RASH; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MYOSITIS; PROGNOSIS; RAYNAUD DISEASE; RETROSPECTIVE STUDIES;

EID: 33745083378     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930600623767     Document Type: Article

References (28)

1. Nishikai, M and Reichlin, M. (1980) Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system Arthritis Rheum, 23(8), pp. 881-888.
2. Pachman, LM and Miller, FW.(2001) Idiopathic inflamamtory myopathies: Dermatomyositis, polymyositis and related disorders. In Samter's immunologic diseases. (pp. 520-530). Philadelphia: Lippincott Williams & Wilkins.
3. Schmidt, WA and Wetzel, W and Friedlander, R and Lange, R and Sorensen, HF and Lichey, HJ et al. (2000) Clinical and serological aspects of patients with anti-Jo-1 antibodies - an evolving spectrum of disease manifestations Clin Rheumatol, 19(5), pp. 371-377.
4. Targoff, IN. (2000) Update on myositis-specific and myositis-associated autoantibodies Curr Opin Rheumatol, 12(6), pp. 475-481.
5. Hausmanowa-Petrusewicz, I and Kowalska-Oledzka, E and Miller, F and Jarzabek-Chorzelska, M and Targoff, IN and Blaszczyk-Kostanecka, M et al. (1997) Clinical, serological and immunogenetic features of Polish patients with idiopathic inflammatory myopathies Arthritis Rheum, 40, pp. 1257-1266.
6. Hirakata, M and Suwa, A and Nagai, S and Kron, MA and Trieu, EP and Mimori, T et al. (1999) Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease J Immunol, 162(4), pp. 2315-2320.
7. Mathews, MB and Reichlin, M and Hughes, GR and Bernstein, RM. (1984) Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody J Exp Med, 160(2), pp. 420-434.
8. Bunn, CC and Bernstein, RM and Mathews, MB. (1986) Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis J Exp Med, 163(5), pp. 1281-1291. May 1
9. Targoff, IN. (1990) Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis J Immunol, 144(5), pp. 1737-1743. Mar 1
10. Miller, FW and Waite, KA and Biswas, T and Plotz, PH. (1990) The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity Proc Natl Acad Sci USA, 87(24), pp. 9933-9937.
11. Nishikai, M and Ohya, K and Kosaka, M and Akiya, K and Tojo, T. (1998) Anti-Jo-1 antibodies in polymyositis or dermatomyositis: Evaluation by ELISA using recombinant fusion protein Jo-1 as antigen Br J Rheumatol, 37(4), pp. 357-361.
12. Peene, I and Meheus, L and Veys, EM and De Keyser, F. (2001) Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing Ann Rheum Dis, 60(12), pp. 1131-1136.
13. Bohan, A and Peter, JB. (1975) Polymyositis and dermatomyositis (in two parts) N Engl J Med, 292, pp. 403.
14. Wortmann, RL.(2001) Inflamatory diseases of muscle and other myopathies. In Kelley's Textbook of Rheumatology. Philadelphia: W.B. Saunders Co.
15. Mastaglia, FL and Phillips, BA. (2002) Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria Rheum Dis Clin North Am, 28(4), pp. 723-741. Nov
16. Kao, AH and Lacomis, D and Lucas, M and Fertig, N and Oddis, CV. (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy Arthritis Rheum, 50(1), pp. 209-215.
17. Franceschini, F and Cavazzana, I and Generali, D and Quinzanini, M and Viardi, L and Ghirardello, A and (2002) Anti-ku antibodies in connective tissue diseases: Clinical and serological evaluation of 14 patients J Rheumatol, 29(7), pp. 1393-1397.
18. Love, LA and Leff, RL and Fraser, DD and Targoff, IN and Dalakas, M and Plotz, PH and (1991) A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups Medicine, 70(6), pp. 360-374.
19. Veeraraghavan, S and Nicholson, AG and Wells, AU. (2001) Lung fibrosis: New classifications and therapy Curr Opin Rheumatol, 13(6), pp. 500-504.
20. Chwalińska-Sadowska, H and Małdykowa, H. (1990) Polymyositis/dermatomyositis: 25 years follow-up of 50 patients. Disease course, treatment, prognostic factors Materia Medica Polona, 75(3), pp. 213.
21. Schnabel, A and Reuter, M and Gross, WL. (1998) Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases Arthritis Rheum, 41(7), pp. 1215-1220. July
22. Cronin, ME and Miller, FW and Hicks, JE and Dalakas, M and Plotz, PH. (1989) The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy J Rheumatol, 16, pp. 1225-1228.
23. Marie, I and Hachulla, E and Cherin, P and Dominique, S and Hatron, PY and Hellot, MF and (2002) Interstitial lung disease in polymyositis and dermatomyositis Arthritis Rheum, 47(6), pp. 614-622.
24. Schnabel, A and Reuter, M and Biederer, J and Richter, C and Gross, WL. (2003) Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment Semin Arthritis Rheum, 32(5), pp. 273-284.
25. Danieli, MG and Malcangi, G and Palmieri, C and Logullo, F and Salvi, A and Piani, M and (2002) Cyclosporin a and intravenous immunoglobulin treatment in polymyositis/dermatomyositis Ann Rheum Dis, 61, pp. 37-42.
26. Grau, JM and (1994) Cyclosporin a as first choice for dermatomyositis J Rheumatol, 21, pp. 381.
27. Bunch, TW. (1981) Prednisone and azathioprine for polymyositis Arthritis Rheum, 24, pp. 45-48.
28. Vencovsky, J and Jarosova, K and Machacek, S and Studynkova, J and Kafkova, J and Bartunkova, J and (2000) Cyclosporine a versus methotrexate in the treatment of polymyositis and dermatomyositis Scand J Rheumatol, 29, pp. 95-102.